Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Leveraging strain competition to address antimicrobial resistance with microbiota therapies

7 Apr 2025

Abstract excerpt

The enteric microbiota is an established reservoir for multidrug-resistant organisms that present urgent clinical and public health threats. Observational data and small interventional studies suggest that microbiome interventions, such as fecal microbiota products and characterized live biotherapeutic bacterial strains, could be an effective antibiotic-sparing prevention approach to address these threats....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Clostridium difficile and Clostridium perfringens research
Share to Gut microbiota and health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40195644
DOI: 10.1080/19490976.2025.2488046

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Leveraging strain competition to address antimicrobial resistance with microbiota therapiesPMID 40195644Read ↗

Suppression of gut colonization by multidrug-resistant Escherichia coli clinical isolates through cooperative niche exclusionSemantic proximity Read ↗

Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogensSemantic proximity Read ↗

Antibiotic resistance in the commensal human gut microbiotaSemantic proximity Read ↗

Competition against the intestinal microbiota selects for pathoadaptive traits in ESBL E. coliSemantic proximity Read ↗

Multi-layered ecological interactions determine growth of clinical antibiotic-resistant strains within human microbiomesSemantic proximity Read ↗

Dysbiosis personalizes fitness effect of antibiotic resistance in the mammalian gutSemantic proximity Read ↗

Antibiotics and the gut microbiotaSemantic proximity Read ↗

Vancomycin promotes key microbiota-pathogen interactions and removes protective bottlenecks to enteric infectionSemantic proximity Read ↗

The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogensSemantic proximity Read ↗

Personalized microbiotas (counter-)select for antibiotic resistant pathogensSemantic proximity Read ↗

Antibiotic treatments and microbes in the gutSemantic proximity Read ↗

Antibiotic Treatment Drives the Diversification of the Human Gut ResistomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.